Athlete AssessmentNCT07103824
Validity and Test-Retest Reliability of Reactive Neurocognitive Upper Extremity Tests in Archers
A study testing Upper Extremity Neurocognitive Tests in people with Athlete Assessment and Archery, run by Balikesir University at 1 site in Turkey (Türkiye).
Trial summary
In archery, the evaluation of reaction time and neurocognitive functions plays a critical role in the management of upper extremity (UE) injuries and return-to-play (RTP) processes. Read more about this study
- Who is it for?
- Ages 10 to 25 yearsHealthy volunteers can take part
- Conditions the study is for
- Athlete Assessment, Archery, Neurocognitive Functional Performance Tests
- What is being tested?
- Upper Extremity Neurocognitive Tests
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 24 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 7 Aug 2024to 12 May 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 25 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- Participants must agree to abstain from alcohol and caffeine throughout the study period.
- Participants must refrain from engaging in vigorous physical activity for at least 24 hours prior to each testing session.
- Participants must not consume any food within 3 hours before the measurement.
Who cannot join
- History of a back, lower extremity, or upper extremity injury within the past six months.
- Any known medical condition or diagnosis that may interfere with testing, including but not limited to neurological disorders.
- Vestibular disorders, color blindness, or the use of medications that could affect balance or visual-motor reaction time.
Trial locations and contacts
1 site in 1 country.
About this study
In archery, the evaluation of reaction time and neurocognitive functions plays a critical role in the management of upper extremity (UE) injuries and return-to-play (RTP) processes. Reaction time reflects an athlete's ability to respond quickly and effectively to visual stimuli, which is particularly crucial in precision-based sports like archery that require high levels of coordination and attention.
With advancements in technology, LED-based systems such as BlazePod™, Catchpad, and ReactionX are increasingly being used in clinical and sports settings to assess cognitive performance and motor responses simultaneously. These tools offer dynamic and motivating methods for evaluating neurocognitive functions. However, before such devices can be reliably used in clinical or research environments, their validity and test-retest reliability must be systematically examined.
Read more
The aim of this study is to evaluate the test-retest reliability and validity of Reactive Neurocognitive Upper Extremity Tests-specifically the Reactive Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) and the Reactive 90/90 Wall Throws Test-using the Catchpad system in archers. Based on methodological standards for reliability studies, a minimum of 18 participants will be included. Each participant will attend three test sessions over three weeks: Catchpad in weeks one and three, and BlazePod™ in week two. To ensure blinding, different researchers will conduct the assessments, record the data, and perform the statistical analyses.
Findings from this study are expected to provide scientific evidence supporting the use of Catchpad technology in neurocognitive and reaction time assessments, contributing to more objective decision-making during RTP and potentially reducing the risk of reinjury.
- Being tested
- Upper Extremity Neurocognitive Tests
- Keywords
- Motor-Cognitive Assessment, Reaction Time, Reactive Upper Limb Tests
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Upper Extremity Neurocognitive TestsOther
The validity and test-retest reliability of the Reactive Neurocognitive Upper Extremity Tests (Reactive CKCUEST and Reactive 90/90 Wall Throws Test) will be analyzed through this protocol. Participants will undergo three assessment sessions spaced one week apart: measurements will be conducted using the Catchpad device during the first and third weeks, and the BlazePod™ device during the second week. To ensure blinding, the personnel responsible for conducting the assessments, recording the data, and performing the statistical analyses will be distinct individuals. Participants will be familiarized with the devices one week prior to testing, and a standardized 5-minute free walking warm-up will be administered at each session. All assessments will be performed under similar environmental conditions and at consistent times of day.
| Study group | Role | What they receive |
|---|---|---|
| Upper Extremity Neurocognitive Tests | Experimental | Not described Receives: Other: Upper Extremity Neurocognitive Tests |
What is being measured
The primary outcome is the main question the study is designed to answer.
REACTIVE CKCUEST+ TEST
The test is performed bilaterally twice, each lasting 15 seconds. Three LED lights are arranged with a distance of 36 inches between them. Two LED lights on the same side are positioned 12 inches apart, while a single LED light is placed centrally between the two lights on the opposite side. The LEDs are arranged in a home base pattern, and the lights are configured to change instantaneously upon being touched, with zero delay. The target colors are set as blue for the two LEDs on the same side and red for the single LED on the opposite side. The athlete begins in a high plank position, with hands centered among the LEDs and feet shoulder-width apart. The participant is instructed to stabilize on one arm and sequentially touch the blue LEDs that light up on the same side, followed by the red LED on the opposite side, alternating between the blue and red LEDs using one hand. The objective is to touch as many lights as possible within the allotted time. Upon completion, the total number
Measured: three times, one week apart, three-week period
REACTIVE 90/90 WALL THROWS TEST
This test is performed bilaterally in two trials of 15 seconds each. Three LED lights are vertically aligned on a wall, spaced 12 inches apart. The lights are positioned 6 inches from the corner, with the middle light placed 5 feet above the ground. An identical setup is arranged on the opposite wall or corner for the contralateral limb. The LEDs are programmed so that one target light (blue) illuminates while the other two display random distracting colors. The lights change immediately upon touch with zero delay.
The athlete stands facing the wall, holding a 2 lb plyoball in 90 degrees of shoulder abduction and 90 degrees of elbow flexion. They are instructed to continuously perform wall throws while maintaining shoulder and elbow alignment, and to touch the target-colored LED as many times as possible with the throwing hand. The non-throwing hand is used to follow the target color. Upon test completion, the total number of touches, number of errors, and average reaction time are r
Measured: three times, one week apart, three-week period
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Aug 2025
- Study start7 Aug 2024
- Primary completion10 Oct 2024
- Study completion12 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Athlete AssessmentStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 24 participants (actual)
Sponsor and investigators
- Lead sponsor
- Balikesir University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ebru Tekin, Balikesir University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07103824
- Sponsor's protocol ID
- 2024/14
- Status last verified
- Jul 2025
- First submitted
- 29 Jul 2025
- Last updated
- 5 Aug 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validity and Test-Retest Reliability of Reactive Neurocognitive Upper Extremity Tests in Archers
- ClinicalTrials.gov ID
- NCT07103824
- Acronym / sponsor ID
- 2024/14
- Keywords
- Motor-Cognitive Assessment, Reaction Time, Reactive Upper Limb Tests
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 24 participants (actual)
- Lead sponsor
- Balikesir UniversityUniversity, hospital or other
- Study start
- 7 Aug 2024 (actual)
- Primary completion
- 10 Oct 2024 (actual)
- Study completion
- 12 May 2025 (actual)
- First posted
- 5 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In archery, the evaluation of reaction time and neurocognitive functions plays a critical role in the management of upper extremity (UE) injuries and return-to-play (RTP) processes. Reaction time reflects an athlete's ability to respond quickly and effectively to visual stimuli, which is particularly crucial in precision-based sports like archery that require high levels of coordination and attention.
With advancements in technology, LED-based systems such as BlazePod™, Catchpad, and ReactionX are increasingly being used in clinical and sports settings to assess cognitive performance and motor responses simultaneously. These tools offer dynamic and motivating methods for evaluating neurocognitive functions. However, before such devices can be reliably used in clinical or research environments, their validity and test-retest reliability must be systematically examined.
The aim of this study is to evaluate the test-retest reliability and validity of Reactive Neurocognitive Upper Extremity Tests-specifically the Reactive Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) and the Reactive 90/90 Wall Throws Test-using the Catchpad system in archers. Based on methodological standards for reliability studies, a minimum of 18 participants will be included. Each participant will attend three test sessions over three weeks: Catchpad in weeks one and three, and BlazePod™ in week two. To ensure blinding, different researchers will conduct the assessments, record the data, and perform the statistical analyses.
Findings from this study are expected to provide scientific evidence supporting the use of Catchpad technology in neurocognitive and reaction time assessments, contributing to more objective decision-making during RTP and potentially reducing the risk of reinjury.
Study design
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Upper Extremity Neurocognitive Tests | Experimental | Other: Upper Extremity Neurocognitive Tests |
Who may qualify
- Ages
- 10 to 25 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (3 listed)
- Participants must agree to abstain from alcohol and caffeine throughout the study period.
- Participants must refrain from engaging in vigorous physical activity for at least 24 hours prior to each testing session.
- Participants must not consume any food within 3 hours before the measurement.
Key exclusion criteria (3 listed)
- History of a back, lower extremity, or upper extremity injury within the past six months.
- Any known medical condition or diagnosis that may interfere with testing, including but not limited to neurological disorders.
- Vestibular disorders, color blindness, or the use of medications that could affect balance or visual-motor reaction time.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Upper Extremity Neurocognitive TestsThe validity and test-retest reliability of the Reactive Neurocognitive Upper Extremity Tests (Reactive CKCUEST and Reactive 90/90 Wall Throws Test) will be analyzed through this protocol. Participants will undergo three assessment sessions spaced one week apart: measurements will be conducted using the Catchpad device during the first and third weeks, and the BlazePod™ device during the second week. To ensure blinding, the personnel responsible for conducting the assessments, recording the data, and performing the statistical analyses will be distinct individuals. Participants will be familiarized with the devices one week prior to testing, and a standardized 5-minute free walking warm-up will be administered at each session. All assessments will be performed under similar environmental conditions and at consistent times of day. | Other | Upper Extremity Neurocognitive Tests |
Primary outcome
REACTIVE CKCUEST+ TEST
Time frame: three times, one week apart, three-week period
The test is performed bilaterally twice, each lasting 15 seconds. Three LED lights are arranged with a distance of 36 inches between them. Two LED lights on the same side are positioned 12 inches apart, while a single LED light is placed centrally between the two lights on the opposite side. The LEDs are arranged in a home base pattern, and the lights are configured to change instantaneously upon being touched, with zero delay. The target colors are set as blue for the two LEDs on the same side and red for the single LED on the opposite side. The athlete begins in a high plank position, with hands centered among the LEDs and feet shoulder-width apart. The participant is instructed to stabilize on one arm and sequentially touch the blue LEDs that light up on the same side, followed by the red LED on the opposite side, alternating between the blue and red LEDs using one hand. The objective is to touch as many lights as possible within the allotted time. Upon completion, the total number
REACTIVE 90/90 WALL THROWS TEST
Time frame: three times, one week apart, three-week period
This test is performed bilaterally in two trials of 15 seconds each. Three LED lights are vertically aligned on a wall, spaced 12 inches apart. The lights are positioned 6 inches from the corner, with the middle light placed 5 feet above the ground. An identical setup is arranged on the opposite wall or corner for the contralateral limb. The LEDs are programmed so that one target light (blue) illuminates while the other two display random distracting colors. The lights change immediately upon touch with zero delay. The athlete stands facing the wall, holding a 2 lb plyoball in 90 degrees of shoulder abduction and 90 degrees of elbow flexion. They are instructed to continuously perform wall throws while maintaining shoulder and elbow alignment, and to touch the target-colored LED as many times as possible with the throwing hand. The non-throwing hand is used to follow the target color. Upon test completion, the total number of touches, number of errors, and average reaction time are r
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Aug 2025.
- Individual participant dataSharing planned: No
Related trials for Athlete Assessment
Active, not recruiting
Effects of Short-term Adaptation to Ketogenic Diet on Endurance Trained Athletes
Ketogenic Diet, Control Condition
Not yet recruiting
Effects of Virtual Reality Exergaming on Reaction Time, Physical Performance, and Muscle Activity in Children
Neuromuscular Performance, Reaction Time
Not yet recruiting
Development, Implementation, and Evaluation of the HADAS Program for the Prevention of Eating Disorders in Adolescent Female Athletes, Coaches, and Families.
Eating Disorders, Body Image Dissatisfaction
Enrolling by invitation
Beetroot Juice and Neuromuscular Performance in Female Basketball Players
Nitrate, Placebo - Control
Not yet recruiting
Core Strength Training, Anthropometry, and Postural Control in Youth Optimist Sailors
Postural Control, Athletic Performance
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Upper Extremity Neurocognitive Tests in people with Athlete Assessment and Archery, run by Balikesir University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
REACTIVE CKCUEST+ TEST (time frame: three times, one week apart, three-week period). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2025.